antibody_discovery_2

In March 2024, Cyagen and Biointron officially signed off on their strategic partnership, forging an alliance in antibody drug development. This partnership aims to fully leverage the strengths of Cyagen's HUGO-Ab™ fully humanized mouse antibody discovery platform and Biointron&#

Single B cell technology accelerates antibody discovery. Biointron demonstrates how this approach delivers potent candidates faster and with greater precision.

AI and computational methods accelerate antibody discovery. Discover how algorithms cut wet-lab cycles, predict properties, and expand the reach of modern biotech.

Talk Title: Innovative Multiple Tech & Platforms Empower Antibody DiscoverySpeaker: Dr.Long Xu, Director, R&D Strategy at BiointronBiointron is excited to announce our upcoming collaborative webinar with the Antibody Society, scheduled for September 26th, 2023. This webinar will featur

Talk Title: Innovative Multiple Tech & Platforms Empower Antibody DiscoverySpeaker: Dr.Long Xu, Director, R&D at BiointronBiointron is thrilled to announce our upcoming collaborative webinar with the Chinese Antibody Society, set to take place on September 16th from 9-10 PM EST (Septem

Explore antibodies with us! Now with a 10% off on your discovery and/or optimization projects!